Clinical Trial

A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

Name: A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. — clinical trial record (NCT07180771)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The objective of this phase II study is to evaluate the efficacy and safety of BR101801 in patients with peripheral T-cell lymphoma(PTCL).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-16.

Trial Details

NCT Number	NCT07180771
Lead Sponsor	Boryung Pharmaceutical Co., Ltd
Conditions	Peripheral T Cell Lymphoma
Enrollment	44 participants
Start Date	2026-02
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-28